Stress echocardiography and myocardial contrast echocardiography in viability assessment.

[1] Packer M. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54. [2] Andrews R, Charlesworth A, Evans A, Cowley AJ. A doubleblind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. Eur Heart J 1997; 18: 852-7. [3] Hampton JR. Results of clinical trials with diuretics in heart failure. Br Heart J 1994; 72 (Suppl): S68-72. [4] Barabino A, Galbaraggi G, Pizzorni C, Lotti G. Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients. Cardiology 1991; 78: 243-56. [5] Dohmen HJM, on behalf of the PRIME-I Study Group. Efficacy and safety of captopril and ibopamine in mild to moderate heart failure. Results of the PRIME-I Study (Abstr). Eur Heart J 1995; 16 (Abstr Suppl): 181. [6] Kleber FX. The economics of cardiac failure. JR Soc Med 1996; 89: 9-12.